SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,250 | -6.4% | 7,580 | +6.2% | 0.01% | 0.0% |
| Q2 2023 | $187,158 | +1.9% | 7,138 | +0.1% | 0.01% | 0.0% |
| Q1 2023 | $183,629 | -1.1% | 7,134 | -0.1% | 0.01% | -25.0% |
| Q4 2022 | $185,685 | +415.8% | 7,139 | +465.2% | 0.01% | +300.0% |
| Q3 2022 | $36,000 | +33.3% | 1,263 | +15.4% | 0.00% | +100.0% |
| Q2 2022 | $27,000 | -55.7% | 1,094 | +6.4% | 0.00% | -50.0% |
| Q1 2022 | $61,000 | +29.8% | 1,028 | +34.7% | 0.00% | 0.0% |
| Q4 2021 | $47,000 | – | 763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |